azithromycin-based macrolide antibiotics (GlaxoSmithKline/Medicines for Malaria Venture)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug Nameazithromycin-based macrolide antibiotics (GlaxoSmithKline/Medicines for Malaria Venture)
Drug Alias Nameazithromycin-based macrolide antibiotics (GSK/MMV)
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics
Mechanisms of Action50S ribosomal subunit inhibitors
Targets50S ribosomal subunit
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline PlcMedicines for Malaria Venture
Active IndicationsN/A
Inactive IndicationsMalaria

Other Information

ATC CodeN/A
Related LinksN/A